LMDX

SC 13G/A - LumiraDx Ltd (0001685428) (Subject)

SC 13G/A - LumiraDx Ltd (0001685428) (Subject)

6-K - LumiraDx Ltd (0001685428) (Filer)

Gainers Syra Health (NASDAQ:SYRA) shares rose 21.2% to $1.5 during Monday's after-market session. The market value of their outstanding shares is at $9.6 million. Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 13.15% to $2.58. The market value of their outstanding shares is at $9.3 million. MaxCyte (NASDAQ:MXCT) shares rose 10.23% to $5.06. The company's market cap stands at $524.0 million. Elevation Oncology (NASDAQ:ELEV) shares rose 7.73% to $1.95. The market value of their outstanding shares is at $82.7 million. MSP Recovery (NASDAQ:LIFW) stock increased by 5.82% to $2.0. The market value of their outstanding shares is at $28.8 million. BrainsWay (NASDAQ:BWAY) stock mo

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 37,596.43 while the NASDAQ rose 1.89% to 14,799.21. The S&P 500 also rose, gaining, 1.11% to 4,749.41. Check This Out: Don't Miss These 3 Consumer Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts   Leading and Lagging Sectors   Information technology shares jumped by 2.1% on Monday. In trading on Monday, energy shares fell by 2.1%.   Top Headline   Commercial Metals Company (NYSE:CMC) posted upbeat earnings for its first quarter on Monday. Commercial Metals posted adjusted earnings of $1.63 per share, beatin

Shares of RxSight, Inc. (NASDAQ:RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41. RxSight shares jumped 20% to $44.31 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Harpoon Therapeutics, Inc. (NASDAQ:HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash. Ambrx Biopharma Inc. (NASDAQ:AMAM) jumped 98.1% to $27.00 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value

Gainers Harpoon Therapeutics (NASDAQ:HARP) stock moved upwards by 112.4% to $22.41 during Monday's regular session. The market value of their outstanding shares is at $379.3 million. Ambrx Biopharma (NASDAQ:AMAM) stock increased by 100.07% to $27.27. The market value of their outstanding shares is at $1.7 billion. Nkarta (NASDAQ:NKTX) shares moved upwards by 52.14% to $9.22. The market value of their outstanding shares is at $452.4 million. Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 38.31% to $2.31. The market value of their outstanding shares is at $8.3 million. Elevation Oncology (NASDAQ:ELEV) stock moved upwards by 36.06% to $1.19. The company's market cap stands at $50

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded down 0.19% to 37,396.28 while the NASDAQ rose 1.20% to 14,698.88. The S&P 500 also rose, gaining, 0.55% to 4,722.93. Check This Out: Don't Miss These 3 Consumer Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts   Leading and Lagging Sectors   Information technology shares jumped by 2% on Monday. In trading on Monday, energy shares fell by 2.2%.   Top Headline   Commercial Metals Company (NYSE:CMC) posted upbeat earnings for its first quarter on Monday. Commercial Metals posted adjusted earnings of $1.63 per share, beating market es

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.45% to 37,296.85 while the NASDAQ rose 0.75% to 14,632.70. The S&P 500 also rose, gaining, 0.26% to 4,709.31. Check This Out: Don't Miss These 3 Consumer Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts   Leading and Lagging Sectors   Information technology shares jumped by 1.1% on Monday. In trading on Monday, energy shares fell by 2.7%.   Top Headline   Commercial Metals Company (NYSE:CMC) posted upbeat earnings for its first quarter on Monday. Commercial Metals posted adjusted earnings of

Shares of LumiraDx Limited (NASDAQ:LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th. LumiraDx shares dipped 30.5% to $0.0239 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Harpoon Therapeutics, Inc.(NASDAQ:HARP) gained 98.6% to $20.95 in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share. Vincerx Pharma, Inc. (NASDAQ:VINC) shares rose 56.3% to $1.86 in pre-market trading after the company announced compelling clinical efficacy of enitociclib in combination with veneto

Gainers Harpoon Therapeutics (NASDAQ:HARP) stock increased by 110.9% to $22.25 during Monday's pre-market session. The company's market cap stands at $376.7 million. Ambrx Biopharma (NASDAQ:AMAM) stock rose 101.76% to $27.5. The market value of their outstanding shares is at $1.7 billion. Vincerx Pharma (NASDAQ:VINC) shares moved upwards by 52.54% to $1.8. The company's market cap stands at $38.4 million. Ampio Pharmaceuticals (AMEX:AMPE) stock rose 27.52% to $2.27. The company's market cap stands at $1.8 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock increased by 25.7% to $3.13. The market value of their outstanding shares is at $3.1 million. Axonics (NASDAQ:AXNX) shares rose 2

LumiraDx Limited (NASDAQ:LMDX)(the "Company") today announced that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") that its securities will be suspended from trading at the open of business on January 9, 2024 as a result of the Company's failure to maintain compliance with Nasdaq's continued listing standards. As previously disclosed, on October 24, 2023, the Company received a notice from Nasdaq's Listing Qualifications Department (the "Staff") stating that the Company's securities were subject to delisting from The Nasdaq Global Market due to a failure to maintain compliance with the minimum bid price requirement of Nasdaq's continued listing standards. The Company

LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ:LMDX)(the "Company") today announced that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") that its securities will be suspended from trading at the open of business on January 9, 2024 as a result of the Company's failure to maintain compliance with Nasdaq's continued listing standards. As previously disclosed, on October 24, 2023, the Company received a notice from Nasdaq's Listing Qualifications Department (the "Staff") stating that the Company's securities were subject to delisting from The Nasdaq Global Market due to a failure to maintain compliance with the minimum bid price requirement of Nasd

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to 14,743.80. The S&P 500 also fell, dropping, 0.66% to 4,738.37. Check This Out: How To Earn $500 A Month From Annaly Capital Management Stock   Leading and Lagging Sectors Health care shares rose by 1.8% on Tuesday. In trading on Tuesday, information technology shares fell by 2.3%.   Top Headline Tesla Inc (NASDAQ:TSLA) reported production and delivery data for the fourth quarter. Tesla said it produced 494,989 vehicles in the fourth quarter, up from 430,488 in the third quarter. The EV mak

Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) rose sharply during Tuesday’s session after the company released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental and Epileptic Encephalopathies (DEEs). Longboard Pharmaceuticals shares jumped 199.7% to $18.07 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Akso Health Group (NASDAQ:AHG) surged 85% to $1.2946. Polished.com Inc. (NYSE:POL) gained 45% to $8.77. Dogness (International) Corporation (NASDAQ:DOGZ) jumped 40% to $7.42. Cue Health Inc. (NASDAQ:HLTH) gained 36.8% to $0.2224 after falling 42% on

Gainers Longboard Pharmaceuticals (NASDAQ:LBPH) shares moved upwards by 200.7% to $18.13 during Tuesday's regular session. The company's market cap stands at $432.5 million. NGM Biopharmaceuticals (NASDAQ:NGM) stock moved upwards by 49.01% to $1.28. The market value of their outstanding shares is at $105.8 million. Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares increased by 37.27% to $3.42. The market value of their outstanding shares is at $70.1 million. SenesTech (NASDAQ:SNES) shares moved upwards by 33.07% to $1.69. The company's market cap stands at $1.2 million. Cue Health (NASDAQ:HLTH) shares moved upwards by 29.29% to $0.21. The company's market cap stands at $32.4 million. Volit

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500 also fell, dropping, 0.45% to 4,748.51. Check This Out: How To Earn $500 A Month From Annaly Capital Management Stock   Leading and Lagging Sectors   Energy shares rose by 1.5% on Tuesday. In trading on Tuesday, information technology shares fell by 2.2%.   Top Headline   Rivian Automotive Inc (NASDAQ:RIVN) reported vehicle production and delivery totals for the fourth quarter. The company produced 17,541 vehicles (vs. 10,020) at its manufacturing facility in Normal, Illinois, and

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ fell 1.35% to 14,808.88. The S&P 500 also fell, dropping, 0.72% to 4,735.41. Check This Out: How To Earn $500 A Month From Annaly Capital Management Stock   Leading and Lagging Sectors   Energy shares rose by 1.1% on Tuesday. In trading on Tuesday, information technology shares fell by 1.8%. Top Headline   The S&P Global manufacturing PMI was revised lower to 47.9 in December versus a preliminary level of 48.2, and versus November’s level of 49.4.   Equities Trading UP   Longboard

Shares of LumiraDx Limited (NASDAQ:LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-care technology platform to Roche. LumiraDx shares dipped 19.7% to $0.0517 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers RiskOn International, Inc. (NASDAQ:ROI) shares gained 89.3% to $0.6298 in pre-market trading after gaining around 17% on Friday. RiskOn International recently said it expects to announce its new generative AI platform and unveil a principal technology partner on Jan. 3. Signing Day Sports, Inc.(NASDAQ:SGN) gained 41.6% to $1.60 in pre-market trading after jumping around 45% on Friday. Cue Health Inc. (

Gainers Longboard Pharmaceuticals (NASDAQ:LBPH) shares increased by 157.0% to $15.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $369.7 million. Cue Health (NASDAQ:HLTH) stock moved upwards by 40.61% to $0.23. The market value of their outstanding shares is at $35.3 million. Voyager Therapeutics (NASDAQ:VYGR) stock rose 27.72% to $10.78. The market value of their outstanding shares is at $474.2 million. NGM Biopharmaceuticals (NASDAQ:NGM) stock rose 26.89% to $1.09. The company's market cap stands at $90.1 million. Estrella Immunopharma (NASDAQ:ESLA) stock rose 15.31% to $1.28. The market value of their outstanding shares is at $45.0 million.

Friday, LumiraDx Limited (NASDAQ:LMDX) appointed joint administrators for two subsidiaries. The administrators signed a definitive agreement to sell certain companies of LumiraDx related to LumiraDx's point-of-care technology to Roche Holdings AG (OTC: RHHBY). Separately, LumiraDx appointed Andrew Johnson, Lisa Rickelton, and Lindsay Hallam of FTI Consulting as joint administrators of two subsidiaries, LumiraDx Group Limited and LumiraDx International Limited, which together hold substantially all of the assets of the LumiraDx group. Roche will pay $295 million and an additional payment of up to $55 million for the reimbursement of amounts to fund the point-of-care diagnostics platform bus

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Sacks Parente Golf, Inc. (NASDAQ:SPGC) announced the resignation of its Chief Executive Officer, Tim Triplett, effective immediately. Greg Campbell will assume responsibilities as Executive Chairman to facilitate a smooth transition. Sacks Parente Golf shares fell 3.9% to $0.6601 in the after-hours trading session. LumiraDx Limited (NASDAQ:LMDX) agreed to sell its point-of-care technology platform to Roche. LumiraDx shares dipped 19.4% to $0.0507 in after-hours trading. Palisade Bio, Inc. (NASDAQ:PALI) filed for offering of shares of common stock. Palisad

Gainers NGM Biopharmaceuticals (NASDAQ:NGM) shares moved upwards by 43.2% to $1.23 during Monday's after-market session. The company's market cap stands at $101.7 million. Cue Health (NASDAQ:HLTH) shares rose 35.38% to $0.22. The market value of their outstanding shares is at $34.0 million. Homology Medicines (NASDAQ:FIXX) stock increased by 12.46% to $0.64. The market value of their outstanding shares is at $36.8 million. Cue Biopharma (NASDAQ:CUE) shares moved upwards by 10.05% to $2.9. The company's market cap stands at $130.8 million. Cadrenal Therapeutics (NASDAQ:CVKD) shares increased by 9.68% to $0.78. The company's market cap stands at $10.1 million. Biophytis (NASDAQ:BPTS) sha